엑셀세라퓨틱스: directors' dealings · South Korea · DART (FSS) DART:company-23a6fa KR KR · DART (FSS) Mcap 16.4Bn€ Healthcare
Explore the full management transaction log of 엑셀세라퓨틱스, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 엑셀세라퓨틱스 has published 6 reports. Market capitalisation: €16.4bn. The latest transaction was reported on 1 April 2026 — Purchase. Among the most active insiders: 김윤신. All data is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 1.95 Bn€
Gross profit −1.95 Bn€ -100% margin
Net income −10.93 Bn€ -560.7% margin
Balance sheet & cash
Market cap 16.41 Bn€
Total debt 5.49 Bn€
Free Cash Flow −10.69 Bn€
Debt / Equity 77%
Profitability & ownership
ROE -134.4%
ROA -41.6%
% insiders 19.8%
% institutions 2.6%
Last declaration on 1 April 2026
Declarations 6 total
Executives ● Purchase19 DART
€5,737 7,080 shares @ €0.8103 0.0000% mcap 100.0% of flow
DART:20260401002832 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Other2 DART
0
DART:20260401002453 · 1 Apr 2026
Executives ● Purchase16 DART
€2,870 3,437 shares @ €0.8352 0.0000% mcap 49.2% of flow
DART:20260330000814 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270) Executives ● Purchase19 DART
€5,918 6,980 shares @ €0.8478 0.0000% mcap 100.0% of flow
DART:20260330000961 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270) Executives ● Purchase11 DART
DART:20260327001248 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270) Executives ● Purchase16 DART
€2,969 3,600 shares @ €0.8248 0.0000% mcap 50.8% of flow
DART:20260320000545 · 17 Mar 2026
Ideal exit: 12 Dec 2026 (T+270)